The microbiota-gut-brain-epigenome axis as a novel therapeutic target for decoding postpartum depression

Area of Science:

• Neuroscience
• Genetics
• Microbiology

Background:

• Postpartum depression (PPD) affects 10-15% of women, impacting maternal and infant well-being.
• Gut microbiome's role in maternal mood is increasingly recognized, alongside hormonal and psychosocial factors.
• The microbiota-gut-brain axis, genetics, and epigenetics are key areas for understanding PPD mechanisms.

Purpose of the Study:

• To review the genetic and epigenetic factors of PPD.
• To explore the gut microbiota's influence on neurobiological outcomes in PPD.
• To identify potential therapeutic strategies based on these interactions.

Main Methods:

• Comprehensive literature search of PubMed, Google Scholar, and NCBI.
• Inclusion of studies on PPD, gut microbiota, genetics, and epigenetics.
• Integration of findings from genomic, epigenomic, and microbiome research.

Main Results:

• Gut microbiota alterations correlate with neuroimmune dysregulation and neurotransmitter imbalances in PPD.
• Genome-wide association studies identify genetic risk loci for PPD; epigenetic factors like DNA methylation are crucial.
• The gut microbiome influences epigenetic modifications, potentially affecting maternal mental health and fetal programming.
• Choline metabolism is linked to PPD risk and is influenced by gut microbiota and brain function.

Conclusions:

• The interplay of genetics, epigenetics, and gut microbiota offers novel insights into PPD.
• The microbiota-gut-brain axis is a critical mediator, influencing neuroimmune and epigenetic pathways.
• Future research should utilize multi-omics approaches for targeted interventions to restore microbiome and epigenetic balance.